Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Program Chairs

Michel Gilliet, MD
University of Lausanne
Lausanne, Switzerland

Michel Gilliet is Chairman of the department of Dermatology at University of Lausanne, CHUV in Lausanne, Switzerland. He received his training in Dermatology at the University of Zürich, Switzerland and his research training in Immunology at the DNAX Research Institute in Palo Alto, California. In 2004, he was recruited to the MD Anderson Cancer Center in Houston, Texas, first as Assistant Professor, then as tenured Associate Professor with a clinical appointment in Dermatology, a translational research appointment in Melanoma Oncology, and a basic science appointment in Immunology. It was in 2010 that he returned to Switzerland and took his current position as Full Professor and Chair of the Department of Dermatology in Lausanne. His research has focused primarily on translational research studying immune responses in psoriasis and other inflammatory skin diseases. In particular, his lab has discovered mechanisms that initiate the inflammatory cascade in psoriatic skin lesions based on the complex formation of DNA with antimicrobial peptides. These studies provided a paradigm shift in the understanding of how inflammation is regulated not only in psoriasis but also in wounded skin and inflammatory diseases such as lupus erythematosus. Dr. Gilliet has also been involved in the initial discovery of TSLP and its role in driving allergic inflammation in atopic dermatitis. These studies have resulted in more than 100 peer-reviewed publications with over 19,000 citations. Dr. Gilliet has served as Secretary Treasurer (2016-17) and President (2018) of the European Society of Dermatological Research (ESDR). In 2016, he received the Cloetta Prize, the most prestigious Award for Medical Research in Switzerland. Gilliet has been an IPC Councilor since 2012.

Last Updated: Aug 19, 2019

Johann Gudjonsson, MD, PhD
University of Michigan
Ann Arbor, Michigan, United States
IPC Board Member

Dr. Johann Gudjonsson, MD, PhD is a graduate of the University of Iceland Medical School. He completed his internship and dermatology residency training at the University of Michigan. In 2008, Dr. Gudjonsson joined the faculty of the University of Michigan Department of Dermatology. Dr. Gudjonsson sees general dermatology patients at the University of Michigan Taubman Center and directs the inpatient consultation service. Dr. Gudjonsson came to the U-M in 2003 as part of an innovative research residency training program. Building upon investigative dermatology training completed in Iceland, Dr. Gudjonsson has been performing basic immunological and genetic work on psoriasis at the U-M. Dr. Gudjonsson's primary research focus is basic immunological and genetic research on psoriasis, with projects directed at improving the diagnosis and treatment of psoriasis. Dr. Gudjonsson is the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. He received the Young Investigator Award from the American Academy of Dermatology in 2007 and his work has earned several research awards, including awards from the American Skin Association, the Dermatology Foundation, Doris Duke Foundation and the NIH.

Last Updated: Jan 08, 2020

Jörg Prinz, MD
Ludwig Maximilians University
Munich, Germany

Jörg C. Prinz is Full Professor of Dermatology and Venereology and Deputy Chair of the Clinic for Dermatology and Allergology of the Ludwig-Maximilian University (LMU) in Munich, Germany. Beyond his commitments in patient care and teaching at medical school his main research interest is in the analysis of the T-cell mediated immunopathogenesis of psoriasis and the identification of the target cells and autoantigens of psoriatic the pathogenic psoriatic immune response; he is also interested in developing novel therapies for T-cell mediated autoimmune disorders, and has been actively involved in preparing evidence-based guidelines for psoriasis treatment. He has published extensively in major peer-reviewed journals.

Last Updated: May 08, 2019


Program Faculty

Hervé Bachelez, MD, PhD
Department of Dermatology, Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, University of Paris
Paris, France
IPC Board Member

Professor Bachelez is professor at the Department of Dermatology of the Saint-Louis University Hospital in Paris, France. Since 2004, Professor Bachelez has been full professor of clinical dermatology at the Université Paris-Diderot/Université de Paris, where he received his Ph.D. in immunology in 1999. Professor Bachelez’s clinical and scientific research focuses on immunogenetics of inflammatory skin diseases at the Institut National de la Santé et de la Recherche Médicale (INSERM) at the Imagine Institute in Necker Hospital. His areas of scientific interest include molecular mechanisms of psoriasis and psoriasis-related diseases, and other immune-mediated and inflammatory skin diseases. Professor Bachelez has received several scientific awards, including the Robert Degos award. He is a member of several national and international scientific societies, including the European Academy of Dermatology and Venereology and the European Dermatology Forum (EDF). He is a board member of the International Psoriasis Council, and general secretary-Treasurer-elect of the European Society for Dermatological Research (ESDR). Professor Bachelez has published more than 230 manuscripts in peer-reviewed journals, including the New England Journal of Medicine , The Lancet , Journal of Clinical Investigation , and Arthritis and Rheumatism as leading author.

Last Updated: Jul 01, 2019

Francesca Capon, PhD
Guy's Hospital
London, England, United Kingdom

Dr. Capon obtained a BSc in biological sciences (1992) and PhD in medical genetics (1999) from La Sapienza, University of Rome, Italy.  Her interest in the genetics of psoriasis brought her to the United Kingdom. She first moved to the University of Leicester as a Wellcome Trust Traveling Research Fellow (2001), then took on a Lectureship in human molecular genetics at University College London (2004). She joined King’s College London in 2006 as a lecturer, was promoted to senior lecturer in 2014, and to reader (associate professor) in 2018. Her main research interest is the genetic basis of psoriasis. In recent years, the Capon lab has been concentrating on two main research lines: the identification of disease genes in pustular forms of psoriasis and the role of interleukin-36 in the pathogenesis of pustular and plaque psoriasis. This research has been published in high-impact journals including the American Journal of Human Genetics, the Journal of Allergy and Clinical Immunology, and Science Translational Medicine.

Last Updated: Oct 09, 2018

Chyung-Ru Wang, PhD
Feinburg School of Medicine, Northwestern Medicine
Chicago, United States

Chyung-Ru Wang, PhD is currently a professor of Microbiology-Immunology at Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois. Professor Wang earned her B.S. in Zoology from the National Taiwan University, Taiwan, R.O.C., and later her Ph.D. at the University of Texas at Austin. She went on to complete her postdoctoral fellow in immunology and biochemistry, both at University of Texas Southwestern Medical School. Professor Wang’s research focuses on identifying the roles of MHC class Ib molecules in T cell development, autoimmunity, and infectious diseases. She has contributed to several major discoveries in her field, and has authored >100 peer-reviewed publications. She served as a section editor for the Journal of Immunology and as an ad hoc reviewer for numerous prestigious journals. Professor Wang is currently a member of the American Association of Immunologists and a member for NIH Host Interactions with Bacterial Pathogens (HIBP) Study Section. Among other honors and awards, she was most recently honored by Northwestern University with the Excellence in Medical Student Teaching award.

Last Updated: May 09, 2019

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.